CIDP is a disease affecting the central and peripheral nervous systems, caused by the immune system attacking the myelin sheath. Symptoms include weakness, numbness, and fatigue. Treatment includes medication and exercise, with regular monitoring. CIDP can go into recession without treatment, but this is rare.
Chronic inflammatory demyelinating polyneuropathy (CIPD) is a disease that affects both the central and peripheral nervous systems. While people of any age or gender can develop CIDP, the disorder usually affects men younger than 30. In some cases, CIDP can disappear as quickly as it developed and never bother the individual again. In other cases, the disorder appears to recur periodically throughout the person’s life. There is also the possibility of lingering side effects from the disorder.
The cause of CIDP appears to be a malfunction of the body’s immune system. As the immune system fights anything perceived as a foreign substance as a threat to the body, the system begins producing antibodies to isolate and eventually eradicate the intruder. CIDP occurs when the immune system begins to identify the myelin sheath that surrounds the nerve fibers of the peripheral nervous system as a foreign substance. As the immune system tries to destroy the sheaths, the nerve fibers are unable to function properly and a variety of CIDP symptoms begin to appear.
The symptoms of CIDP are focused on the development and progression of leg and arm problems. When the sheaths around peripheral nerves are weakened, sensory function and the ability to control movement are impaired. An individual with CIDP will often begin to experience a sense of weakness in the arms and legs that seems to get worse over time, even with regular exercise. There may also be numbness or a tingling sensation in the fingers and toes. Overwhelming fatigue is also a common symptom.
Fortunately, there are effective ways to treat the symptoms of CIDP. When identified in the early stages, treatment for CIDP will usually employ a combination of regular exercise and the use of medications that will help suppress the production of antibodies that attack the myelin sheath. Intravenous immunoglobulin therapy can be used to relieve some of the symptoms, such as numbness or loss of sensation in the extremities. In some cases, the treatment of CIDP may include the use of corticosteroids along with the application of drugs to suppress immune system function. During the treatment phase, it is important to monitor progress regularly and adjust the treatment process as needed.
It is possible for CIDP to go into recession without the use of medication or intravenous therapy of any kind. However, this is usually not the case.
Protect your devices with Threat Protection by NordVPN
